andes-1537
Nucleic acidexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2015 (NCT02508441)
Timeline
2010s
- Jan 1, 2015
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- MitochondriaINHIBITOR
Mitochondria inhibitor
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- andes-1537
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03985072 | Phase 1 | Apr 26, 2019 | Andes Biotechnologies |
| NCT02508441 | Phase 1 | Dec 1, 2015 | Andes Biotechnologies, University of California, San Francisco |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Andes Biotechnologies | For profit | 2 | 2 | 1 | 2015 |
| University of California, San Francisco | Academic/Hospital | 1 | 0 | 1 | 2015 |
2 organizations
Page 1 / 1